<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01313676</url>
  </required_header>
  <id_info>
    <org_study_id>113782</org_study_id>
    <nct_id>NCT01313676</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if fluticasone furoate/vilanterol improves survival
      in patients with chronic obstructive pulmonary disease with a history of or increased risk of
      heart disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite a potential link between the pathogenetic mechanisms involved in Chronic Obstructive
      Pulmonary Disease (COPD) and atherosclerotic cardiovascular disease, there are no currently
      approved therapies for patients with COPD that have clearly shown an additional beneficial
      effect in patients with cardiovascular comorbidities. The TOwards a Revolution in COPD Health
      (TORCH) study assessed the impact of the inhaled corticosteroid (ICS) fluticasone propionate
      (FP) in combination with the long-acting beta agonist (LABA), salmeterol (SAL), in reducing
      all-cause mortality. TORCH demonstrated a 17.5% reduction on all-cause mortality with
      salmeterol-fluticasone propionate combination (SFC) compared with placebo (HR=0.825, 95% CI
      (0.681, 1.002), p=0.052) in the entire COPD population with disease severity form moderate to
      very severe. A post hoc analysis of the data restricted to those subjects with an forced
      expiratory volume in 1 second (FEV1) &gt;=50% predicted with an apparent history of
      cardiovascular co-morbidities (defined as use at baseline of beta-blockers, angiotensin
      converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB), HMG CoA reductase
      inhibitors (i.e. statins) or a prior MI recorded at baseline) demonstrated a 49% reduction in
      the risk of dying within 96 weeks for the comparison of SFC with placebo. These post hoc data
      suggest the possibility of an ICS/LABA combination product to be of substantial benefit in
      COPD subjects with less severe airflow obstruction yet with increased cardiovascular risk.

      The mechanism by which SFC appears to be associated with a greater reduction in mortality in
      these less severe COPD subjects with concomitant cardiovascular comorbidities is speculative
      at present, but could potentially in part be related to a lessening of the degree of
      inflammation in the systemic circulation, potential plaque stabilization and/or amelioration
      of arterial stiffness.

      ICS/LABA combinations that are currently available require twice daily administration. A once
      daily ICS/LABA combination has the potential to improve patient compliance and as a result,
      overall disease management.

      The purpose of this study is to prospectively evaluate the effect of the once daily ICS/LABA
      combination Fluticasone Furoate (FF)/Vilanterol (VI) on survival in subjects with moderate
      COPD (&gt;=50 and =&lt;70 % predicted FEV1 ) and a history of, or at increased risk for
      cardiovascular disease.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 25, 2011</start_date>
  <completion_date type="Actual">July 15, 2015</completion_date>
  <primary_completion_date type="Actual">July 15, 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Death (Both on and Off Treatment) Due to Any Cause, Time up to or on the Pre-determined Common End Date</measure>
    <time_frame>From the date of randomization until date of death due to any cause (average of 2 study years)</time_frame>
    <description>Death from any cause: which occurred from the day of starting IP until the Commone End Date (CED). Common End Date (CED) is the study end date that was pre determined where approximately 1000 deaths would have occurred in the Intent-toTreat Efficacy (ITT-E) Population. Only deaths which occurred on or before the CED were used for the primary analysis. Those who had not died by CED, but who were known to be alive on or after the CED, were censored at the CED. Cox Proportional Hazards (PH) Model was adjusted for age, and gender, including all 4 arms. A hazard ratio of less than 1 indicates a lower death rate versus placebo or other arm. ITT-E Population consisted of all participants in the Safety Population (i.e. randomized to IP and who received at least one dose of IP), with the exception of those recruited at sites that were closed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decline in Forced Expiratory Volume in 1 Second (FEV1)</measure>
    <time_frame>From start date of IP until IP stop date + 1 (assessed up to 4 years)</time_frame>
    <description>FEV1 is a measure of lung function and is defined as the maximal amount of air that can be forcefully exhaled in one second. The effect of treatment on decline of post bronchodilator FEV1 recorded during the treatment period was analyzed using a particular form of a mixed effect model - a random coefficients model. FEV1 was fitted as the response variable with treatment group, age, gender, baseline FEV1 and time on treatment as fixed effects. Time on treatment was treated as a continuous variable. This model allowed for an initial increase in FEV1, but then tested the difference in slopes from the first post-baseline measurement which was at 3 months. A negative slope indicates a decline. A positive treatment difference indicates a slower rate of decline vs Placebo or Component. Only participants with at least one on-treatment post-bronchodilator FEV1 measurement were analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With First On-treatment Cardiovascular (CV) Composite Events Occured on or Before Common End Date</measure>
    <time_frame>From the start of IP to first on treatment CV event till 7 days after the last dose of IP (average of 2 study years)</time_frame>
    <description>On-treatment CV composite event is comprised of the first event that is adjudicated as on-treatment CV death, myocardial infarction, stroke, unstable angina, or transient ischemic attack experienced by a participant. The events that occurred no more than 7 days after the participants last dose of IP are considered as on-treatment adverse events. Common end date is the study end date where approximately 1000 deaths would have occurred in the ITT-E Population. Cox PH Model was used to assess time to first on-treatment CV composite event. Cox PH Model was adjusted for age, gender and indicators of ischemic and vascular disease, including all four treatment arms. A hazard ratio less than 1 indicates a lower risk of a first CV event rate versus placebo or any arm.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16568</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>fluticasone furoate/vilanterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of both products in one inhaler</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fluticasone furoate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>comparator of individual component</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vilanterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>comparator of individual component</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>once daily via inhaler</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluticasone furoate/vilanterol</intervention_name>
    <description>100/25mcg given once daily via novel dry powder inhaler</description>
    <arm_group_label>fluticasone furoate/vilanterol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluticasone furoate</intervention_name>
    <description>100mcg given once daily via novel dry powder inhaler</description>
    <arm_group_label>fluticasone furoate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vilanterol</intervention_name>
    <description>25mcg given once daily via novel dry powder inhaler</description>
    <arm_group_label>vilanterol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo comparator once daily via novel dry powder inhaler</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type of subject: outpatient.

          -  Informed consent: Subjects must give their signed and dated written informed consent
             to participate.

          -  Gender: Male or female. Female subjects must be post-menopausal or using a highly
             effective method for avoidance of pregnancy. The decision to include or exclude women
             of childbearing potential may be made at the discretion of the investigator in
             accordance with local practice in relation to adequate contraception.

          -  Age: &gt;=40 and &lt;=80 years of age at Screening (Visit 1).

          -  Tobacco use: Subjects with a current or prior history of &gt;=10 pack-years of cigarette
             smoking at screening (Visit 1). Previous smokers are defined as those who have stopped
             smoking for at least 6 months prior to Visit 1.

          -  Airflow Obstruction:

        Subjects with a measured post-albuterol/salbutamol forced expiratory volume in 1 second
        (FEV1)/(forced vital capacity)FVC ratio of &lt;=0.70 at Screening (Visit 1).

        Subjects with a measured post-albuterol/salbutamol FEV1 &gt;=50 and &lt;=70% of predicted normal
        values calculated using NHANES III reference equations [Hankinson, 1999; Hankinson, 2010]
        at Screening (Visit 1).

        Post-bronchodilator spirometry will be performed approximately 15 minutes after the subject
        has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via a
        metered dose inhaler (MDI )with a valved-holding chamber. The FEV1/FVC ratio and FEV1
        percent predicted values will be calculated.

          -  Symptoms of COPD: Subjects must score 2 or higher on the modified Medical Research
             Council Dyspnea scale (Visit 1)

          -  Cardiovascular disease:

        For patients &gt;= 40 years of age: any one of the following:

        Established (i.e. by clinical signs or imaging studies) coronary artery disease (CAD)
        Established (i.e. by clinical signs or imaging studies) peripheral vascular disease (PVD)
        Previous stroke Previous MI Diabetes mellitus with target organ disease OR

        For patients &gt;=60 years of age: any 2 of the following:

        Being treated for hypercholesterolemia Being treated for hypertension Being treated for
        diabetes mellitus Being treated for peripheral vascular disease

        Exclusion Criteria:

          -  Pregnancy: Women who are pregnant or lactating.

          -  Asthma: Subjects with a current diagnosis of asthma. (Subjects with a prior history of
             asthma are eligible if they also have a current diagnosis of COPD).

          -  alpha 1-antitrypsin deficiency: Subjects with known alpha-1 antitrypsin deficiency as
             the underlying cause of COPD.

          -  Other respiratory disorders: Subjects with active tuberculosis, lung cancer,
             bronchiectasis, sarcoidosis, pulmonary fibrosis, pulmonary hypertension, interstitial
             lung diseases or other active pulmonary diseases.

          -  Lung resection or transplantation: Subjects with lung volume reduction surgery within
             the 12 months prior to Screening or having had a lung transplant.

          -  A moderate/severe COPD exacerbation that has not resolved at least 14 days prior to
             Visit 1 and at least 30 days following the last dose of oral corticosteroids (if
             applicable).

          -  Current severe heart failure (New York Heart Association class IV). Subjects will also
             be excluded if they have a known ejection fraction of &lt;30% or if they have an
             implantable cardioverter defibrillator (ICD).

          -  Other diseases/abnormalities: Any life-threatening condition with life expectancy &lt;3
             years, other than vascular disease or COPD, that might prevent the subject from
             completing the study.

          -  End stage chronic renal disease: Subjects will be excluded if on renal replacement
             therapy (hemodialysis or peritoneal).

          -  Drug/food allergy: Subjects with a history of hypersensitivity to any of the study
             medications (e.g. beta-agonists, corticosteroid) or components of the inhalation
             powder (e.g. lactose, magnesium stearate). In addition, patients with a history of
             severe milk protein allergy that, in the opinion of the study physician,
             contraindicates the subject's participation will also be excluded.

          -  Drug/alcohol abuse: Subjects with a known or suspected history of alcohol or drug
             abuse within the last 2 years.

          -  Oxygen therapy: Subjects receiving treatment with long-term oxygen therapy (LTOT) or
             nocturnal oxygen therapy required for greater than 12 hours a day. Oxygen prn use
             (i.e. &lt;=12 hours per day) is not exclusionary.

          -  Questionable validity of consent: Subjects with a history of psychiatric disease,
             intellectual deficiency, poor motivation or other conditions that will limit the
             validity of informed consent to participate in the study or the potential compliance
             to study procedures.

          -  Affiliation with investigator site: Study investigators, sub-investigators, study
             coordinators, employees of a participating investigator or immediate family members of
             the aforementioned are excluded from participating in this study.

          -  Additional medication: Use of the following medications within the following time
             intervals prior to Visit 1 or during the study (unless otherwise specified):

        Medication No use within the following time intervals prior to Screening or thereafter at
        any time during the study (unless otherwise specified) Inhaled Long acting beta-agonists
        (LABA) 48 hours ICS/LABA combination products 48 hours Inhaled corticosteroids 48 hours
        Tiotropium 1 week Systemic, Oral, parenteral, intra-articular corticosteroids 30 days (oral
        and systemic corticosteroids may be used to treat COPD exacerbations during the study)
        Cytochrome P450 3A4 strong inhibitors including but not limited to antiretrovirals
        (protease inhibitors) (e.g.Indinavir, Nelfinavir, Ritonavir, Saquinavir); Imidazole and
        Triazole anti-fungals (e.g. Ketaconazole, Itraconazole); Clarithromycin, Telithromycin,
        Amiodarone, and Nefazodone 6 weeks Grapefruit is allowed up to Visit 1, then limited to no
        more than one glass of grapefruit juice (250 mL/ 8 ounces) or one grapefruit per day Any
        other investigational drug 30 days or 5 half lives whichever is longer.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Andalusia</city>
        <state>Alabama</state>
        <zip>36420</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Athens</city>
        <state>Alabama</state>
        <zip>35611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Muscle Shoals</city>
        <state>Alabama</state>
        <zip>35662</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ozark</city>
        <state>Alabama</state>
        <zip>36360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pell City</city>
        <state>Alabama</state>
        <zip>35128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tuscumbia</city>
        <state>Alabama</state>
        <zip>35674</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Flagstaff</city>
        <state>Arizona</state>
        <zip>86001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sierra Vista</city>
        <state>Arizona</state>
        <zip>85635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cerritos</city>
        <state>California</state>
        <zip>90703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Foothill Ranch</city>
        <state>California</state>
        <zip>92610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gold River</city>
        <state>California</state>
        <zip>95670</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92647</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huntington Park</city>
        <state>California</state>
        <zip>90255</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lakewood</city>
        <state>California</state>
        <zip>90712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <zip>93534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92357</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <zip>91345</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Montclair</city>
        <state>California</state>
        <zip>91763</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Monterey Park</city>
        <state>California</state>
        <zip>91754</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oxnard</city>
        <state>California</state>
        <zip>93030-5841</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <zip>93449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rolling Hills Estates</city>
        <state>California</state>
        <zip>90274</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95821</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>91910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Gabriel</city>
        <state>California</state>
        <zip>91776</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Marino</city>
        <state>California</state>
        <zip>91108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sepulveda</city>
        <state>California</state>
        <zip>91343</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Simi Valley</city>
        <state>California</state>
        <zip>93065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Stockton</city>
        <state>California</state>
        <zip>95207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Van Nuys</city>
        <state>California</state>
        <zip>91405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>West Covina</city>
        <state>California</state>
        <zip>91790</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Centennial</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80528</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <zip>80033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <zip>06810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <zip>06708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20422</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Altamonte Springs</city>
        <state>Florida</state>
        <zip>32714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bay Pines</city>
        <state>Florida</state>
        <zip>33744</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33472</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Celebration</city>
        <state>Florida</state>
        <zip>34747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33755</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33759</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33765-2616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33765</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Crystal River</city>
        <state>Florida</state>
        <zip>34429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>DeBary</city>
        <state>Florida</state>
        <zip>32173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edgewater</city>
        <state>Florida</state>
        <zip>32132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fleming Island</city>
        <state>Florida</state>
        <zip>32003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leesburg</city>
        <state>Florida</state>
        <zip>34748</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lehigh Acres</city>
        <state>Florida</state>
        <zip>33971</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Maitland</city>
        <state>Florida</state>
        <zip>32751</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32934</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami Gardens</city>
        <state>Florida</state>
        <zip>33169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33142</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33174</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33175</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33185</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33186</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34652</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>North Miami Beach</city>
        <state>Florida</state>
        <zip>33179</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oakland Park</city>
        <state>Florida</state>
        <zip>33309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34471</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32811</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Palm Harbor</city>
        <state>Florida</state>
        <zip>34684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pinellas Park</city>
        <state>Florida</state>
        <zip>33781</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33709</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Summerfield</city>
        <state>Florida</state>
        <zip>34491</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Trinity</city>
        <state>Florida</state>
        <zip>34655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32958</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zephyrhills</city>
        <state>Florida</state>
        <zip>33540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Austell</city>
        <state>Georgia</state>
        <zip>30106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Blue Ridge</city>
        <state>Georgia</state>
        <zip>30513</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Calhoun</city>
        <state>Georgia</state>
        <zip>30701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Canton</city>
        <state>Georgia</state>
        <zip>30114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cumming</city>
        <state>Georgia</state>
        <zip>30041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <zip>30046</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rincon</city>
        <state>Georgia</state>
        <zip>31326</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Suwanee</city>
        <state>Georgia</state>
        <zip>30024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Woodstock</city>
        <state>Georgia</state>
        <zip>30189</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Coeur d'Alene</city>
        <state>Idaho</state>
        <zip>90212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hayden Lake</city>
        <state>Idaho</state>
        <zip>83835</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nampa</city>
        <state>Idaho</state>
        <zip>83687</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Champaign</city>
        <state>Illinois</state>
        <zip>61820</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Evergreen Park</city>
        <state>Illinois</state>
        <zip>60805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gillespie</city>
        <state>Illinois</state>
        <zip>62033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Melrose Park</city>
        <state>Illinois</state>
        <zip>60160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>North Chicago</city>
        <state>Illinois</state>
        <zip>60064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quincy</city>
        <state>Illinois</state>
        <zip>62301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>River Forest</city>
        <state>Illinois</state>
        <zip>60305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Avon</city>
        <state>Indiana</state>
        <zip>46123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Elwood</city>
        <state>Indiana</state>
        <zip>46036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Franklin</city>
        <state>Indiana</state>
        <zip>46131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greenfield</city>
        <state>Indiana</state>
        <zip>46140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <zip>47304-5547</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Valparaiso</city>
        <state>Indiana</state>
        <zip>46383</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Council Bluffs</city>
        <state>Iowa</state>
        <zip>51503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dubuque</city>
        <state>Iowa</state>
        <zip>52001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50265</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Olathe</city>
        <state>Kansas</state>
        <zip>66061</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bowling Green</city>
        <state>Kentucky</state>
        <zip>42101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hawesville</city>
        <state>Kentucky</state>
        <zip>42348</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hazard</city>
        <state>Kentucky</state>
        <zip>41701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303-3163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Opelousas</city>
        <state>Louisiana</state>
        <zip>70570</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <zip>04210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Biddeford</city>
        <state>Maine</state>
        <zip>04005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Elkton</city>
        <state>Maryland</state>
        <zip>21921</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hagerstown</city>
        <state>Maryland</state>
        <zip>21740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hollywood</city>
        <state>Maryland</state>
        <zip>20636</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lutherville</city>
        <state>Maryland</state>
        <zip>21093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oxon Hill</city>
        <state>Maryland</state>
        <zip>20745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>North Dartmouth</city>
        <state>Massachusetts</state>
        <zip>02747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buckley</city>
        <state>Michigan</state>
        <zip>49620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cadillac</city>
        <state>Michigan</state>
        <zip>49601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Niles</city>
        <state>Michigan</state>
        <zip>49120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>Michigan</state>
        <zip>48307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073-6769</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <zip>49684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fridley</city>
        <state>Minnesota</state>
        <zip>55432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plymouth</city>
        <state>Minnesota</state>
        <zip>55441</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Woodbury</city>
        <state>Minnesota</state>
        <zip>55125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <zip>59701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bellevue</city>
        <state>Nebraska</state>
        <zip>68123-4303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fremont</city>
        <state>Nebraska</state>
        <zip>68025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <zip>68803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>02865</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68512</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brick</city>
        <state>New Jersey</state>
        <zip>08723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>8820</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Elizabeth</city>
        <state>New Jersey</state>
        <zip>07201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Elizabeth</city>
        <state>New Jersey</state>
        <zip>07202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Freehold</city>
        <state>New Jersey</state>
        <zip>07728</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Linden</city>
        <state>New Jersey</state>
        <zip>07036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodi</city>
        <state>New Jersey</state>
        <zip>07644</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Margate City</city>
        <state>New Jersey</state>
        <zip>08402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Princeton</city>
        <state>New Jersey</state>
        <zip>08540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salem</city>
        <state>New Jersey</state>
        <zip>08079</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Verona</city>
        <state>New Jersey</state>
        <zip>07044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bronxville</city>
        <state>New York</state>
        <zip>10708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10457</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215-1199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Corning</city>
        <state>New York</state>
        <zip>14830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Manhattan</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Massapequa</city>
        <state>New York</state>
        <zip>11758</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10038</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Westfield</city>
        <state>New York</state>
        <zip>14787</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Calabash</city>
        <state>North Carolina</state>
        <zip>28467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Elizabeth City</city>
        <state>North Carolina</state>
        <zip>27909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27408</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27858</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huntersville</city>
        <state>North Carolina</state>
        <zip>28078</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Knightdale</city>
        <state>North Carolina</state>
        <zip>27545</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lexington</city>
        <state>North Carolina</state>
        <zip>27295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Morganton</city>
        <state>North Carolina</state>
        <zip>28655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shelby</city>
        <state>North Carolina</state>
        <zip>28152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Smithfield</city>
        <state>North Carolina</state>
        <zip>27577</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44313</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chardon</city>
        <state>Ohio</state>
        <zip>44024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45459</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Maumee</city>
        <state>Ohio</state>
        <zip>43537-9402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Miamisburg</city>
        <state>Ohio</state>
        <zip>45342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614-5809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wooster</city>
        <state>Ohio</state>
        <zip>44691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Youngstown</city>
        <state>Ohio</state>
        <zip>44501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <zip>15009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Belle Vernon</city>
        <state>Pennsylvania</state>
        <zip>15012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bensalem</city>
        <state>Pennsylvania</state>
        <zip>19020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Clairton</city>
        <state>Pennsylvania</state>
        <zip>15025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Downingtown</city>
        <state>Pennsylvania</state>
        <zip>19335</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fleetwood</city>
        <state>Pennsylvania</state>
        <zip>19522</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Harleysville</city>
        <state>Pennsylvania</state>
        <zip>19438</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jersey Shore</city>
        <state>Pennsylvania</state>
        <zip>17740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Langhorne</city>
        <state>Pennsylvania</state>
        <zip>19047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <zip>19446</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Monroeville</city>
        <state>Pennsylvania</state>
        <zip>15146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19142</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Phoenixville</city>
        <state>Pennsylvania</state>
        <zip>19460</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Scottdale</city>
        <state>Pennsylvania</state>
        <zip>15683</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <zip>18501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warminster</city>
        <state>Pennsylvania</state>
        <zip>18974</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cumberland</city>
        <state>Rhode Island</state>
        <zip>02864</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>East Providence</city>
        <state>Rhode Island</state>
        <zip>02914</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Johnston</city>
        <state>Rhode Island</state>
        <zip>02919</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29406-7108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Easley</city>
        <state>South Carolina</state>
        <zip>29640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Florence</city>
        <state>South Carolina</state>
        <zip>29501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gaffney</city>
        <state>South Carolina</state>
        <zip>29340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greenwood</city>
        <state>South Carolina</state>
        <zip>29646</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29650</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Indian Land</city>
        <state>South Carolina</state>
        <zip>29707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Murrells Inlet</city>
        <state>South Carolina</state>
        <zip>29576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pelzer</city>
        <state>South Carolina</state>
        <zip>29669</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rock Hill</city>
        <state>South Carolina</state>
        <zip>29732</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Williamston</city>
        <state>South Carolina</state>
        <zip>29697</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dakota Dunes</city>
        <state>South Dakota</state>
        <zip>57049</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fayetteville</city>
        <state>Tennessee</state>
        <zip>37334</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>27064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shelbyville</city>
        <state>Tennessee</state>
        <zip>37160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Boerne</city>
        <state>Texas</state>
        <zip>78006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Corsicana</city>
        <state>Texas</state>
        <zip>75110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75254</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Duncanville</city>
        <state>Texas</state>
        <zip>75116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edinburg</city>
        <state>Texas</state>
        <zip>78539</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Frisco</city>
        <state>Texas</state>
        <zip>75034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Frisco</city>
        <state>Texas</state>
        <zip>75035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Georgetown</city>
        <state>Texas</state>
        <zip>78626</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77077</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77079</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77099</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huntsville</city>
        <state>Texas</state>
        <zip>77340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Killeen</city>
        <state>Texas</state>
        <zip>76543</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lewisville</city>
        <state>Texas</state>
        <zip>75067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Longview</city>
        <state>Texas</state>
        <zip>75605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lufkin</city>
        <state>Texas</state>
        <zip>75904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75071</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Angelo</city>
        <state>Texas</state>
        <zip>76904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Victoria</city>
        <state>Texas</state>
        <zip>77901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Midvale</city>
        <state>Utah</state>
        <zip>84047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orem</city>
        <state>Utah</state>
        <zip>84058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>West Jordan</city>
        <state>Utah</state>
        <zip>84088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Abingdon</city>
        <state>Virginia</state>
        <zip>24210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Midlothian</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23454</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Burien</city>
        <state>Washington</state>
        <zip>98166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bridgeport</city>
        <state>West Virginia</state>
        <zip>26330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>28506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>West Allis</city>
        <state>Wisconsin</state>
        <zip>53227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Adrogue</city>
        <state>Buenos Aires</state>
        <zip>B1846DSK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bahia Blanca</city>
        <state>Buenos Aires</state>
        <zip>B8000FTD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ciudad Autnnoma de Buenos Aires</city>
        <state>Buenos Aires</state>
        <zip>C1186ACB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <state>Buenos Aires</state>
        <zip>C1028AAP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <state>Buenos Aires</state>
        <zip>C1122AAK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <state>Buenos Aires</state>
        <zip>C1405BCH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Derqui, Pilar</city>
        <state>Buenos Aires</state>
        <zip>B1629AHJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Florencio Varela</city>
        <state>Buenos Aires</state>
        <zip>1888</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>B1900AXI</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <state>Buenos Aires</state>
        <zip>B7600FZN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nueve de Julio</city>
        <state>Buenos Aires</state>
        <zip>B6500BWQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Olivos</city>
        <state>Buenos Aires</state>
        <zip>B1605DSX</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pergamino</city>
        <state>Buenos Aires</state>
        <zip>B2700CPM</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quilmes</city>
        <state>Buenos Aires</state>
        <zip>1878</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quilmes</city>
        <state>Buenos Aires</state>
        <zip>B1878FNR</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Isidro</city>
        <state>Buenos Aires</state>
        <zip>B1642DCD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Martin</city>
        <state>Buenos Aires</state>
        <zip>1650</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Nicolas</city>
        <state>Buenos Aires</state>
        <zip>B2900DMH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Nicolas</city>
        <state>Buenos Aires</state>
        <zip>B2900IIC</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vicente Lpez</city>
        <state>Buenos Aires</state>
        <zip>1602</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <state>Crdova</state>
        <zip>X5000AAW</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <state>Crdova</state>
        <zip>X5003DCE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Concepcion del Uruguay</city>
        <state>Entre Ros</state>
        <zip>3260</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Parana</city>
        <state>Entre Ros</state>
        <zip>E3100BHK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Godoy Cruz</city>
        <state>Mendoza</state>
        <zip>5501</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cipoletti, Rio Negro</city>
        <state>Ro Negro</state>
        <zip>R8324CVE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000BIF</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000CVD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2002OJN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2005PAF</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tucuman</city>
        <state>Tucumn</state>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>B1704ETD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1061ABD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1120AAC</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1280AEB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1407HUF</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1425AGC</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1425FVH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1437BZ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <zip>C1425BEN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ciudad Autnoma de Buenos Aires</city>
        <zip>C1426ABP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>5016</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>5900</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5003DCE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5004BAL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5006</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Coronel Suarez</city>
        <zip>7540</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400AVK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Florencio Varela</city>
        <zip>C1073ABA</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Formosa</city>
        <zip>3600</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jujuy</city>
        <zip>4600</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lans</city>
        <zip>B1824KAJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <zip>B7600FYK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mendoza</city>
        <zip>5500</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mendoza</city>
        <zip>M5500CCG</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mendoza</city>
        <zip>MM5500</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Monte Grande</city>
        <zip>1842</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rosario</city>
        <zip>S2000CXP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salta</city>
        <zip>A4400ANG</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salta</city>
        <zip>A4400ERH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Luis</city>
        <zip>5700</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Miguel de Tucumn</city>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santa Fe</city>
        <zip>3000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santa Fe</city>
        <zip>3016</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santiago del Estero</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cairns</city>
        <state>Queensland</state>
        <zip>4870</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Redcliffe</city>
        <state>Queensland</state>
        <zip>4020</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daw Park</city>
        <state>South Australia</state>
        <zip>5041</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Footscray</city>
        <state>Victoria</state>
        <zip>3011</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Glen Osmond</city>
        <zip>5064</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Feldbach</city>
        <zip>8330</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Feldkirch</city>
        <zip>6800</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Grieskirchen</city>
        <zip>A-4710</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Salzburg</city>
        <zip>A-5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spittal/Drau</city>
        <zip>9800</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Thalheim bei Wels</city>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vienna</city>
        <zip>A-1120</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wels</city>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zwettl</city>
        <zip>3910</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brest</city>
        <zip>224027</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gomel</city>
        <zip>246040</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Grodno</city>
        <zip>230017</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Minsk</city>
        <zip>220030</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Minsk</city>
        <zip>220053</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Minsk</city>
        <zip>223041</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vitebsk</city>
        <zip>210037</zip>
        <country>Belarus</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Diest</city>
        <zip>3290</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Erpent</city>
        <zip>5101</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gilly</city>
        <zip>6060</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mons</city>
        <zip>7000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Namur</city>
        <zip>5000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Banja Luka</city>
        <zip>78000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Banjaluka</city>
        <zip>78000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bihac</city>
        <zip>77 000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bihac</city>
        <zip>77000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bijeljina</city>
        <zip>76300</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brcko</city>
        <zip>76000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Foca</city>
        <zip>73300</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gracanica</city>
        <zip>75320</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gradiska</city>
        <zip>78400</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Istocno Sarajevo</city>
        <zip>71123</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Konjic</city>
        <zip>88400</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mostar</city>
        <zip>88000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novi Travnik</city>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pale</city>
        <zip>71420</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sarajevo</city>
        <zip>71000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sarajevo</city>
        <zip>71320</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Srebrenik</city>
        <zip>75350</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tesanj</city>
        <zip>74260</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tesli</city>
        <zip>74270</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Travnik</city>
        <zip>72270</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Trebinje</city>
        <zip>89101</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tuzla</city>
        <zip>75000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Visegrad</city>
        <zip>73240</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zenica</city>
        <zip>72000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Blagoevgrad</city>
        <zip>2700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dimitrovgrad</city>
        <zip>6400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gabrovo</city>
        <zip>5300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kozlodui</city>
        <zip>3320</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lovech</city>
        <zip>5500</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pazardjik</city>
        <zip>4400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Petrich</city>
        <zip>2850</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Razgrad</city>
        <zip>7200</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rousse</city>
        <zip>7000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sevlievo</city>
        <zip>5400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sliven</city>
        <zip>8800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1142</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1202</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1233</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1336</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1505</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1618</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sofia</city>
        <zip>1784</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6003</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Troyan</city>
        <zip>5600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Varna</city>
        <zip>9000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Veliko Tarnovo</city>
        <zip>5000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vidin</city>
        <zip>3700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5A 4L8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5J 3S9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kamloops</city>
        <state>British Columbia</state>
        <zip>V2C 1K7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Penticton</city>
        <state>British Columbia</state>
        <zip>V2A 5C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 4E1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>West Vancouver</city>
        <state>British Columbia</state>
        <zip>V7T 2Z3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bolton</city>
        <state>Ontario</state>
        <zip>L7E 4C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7N 3V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Grimsby</city>
        <state>Ontario</state>
        <zip>L3M 1P3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N5Y 5K7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L4T 4J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5M 2V8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orleans</city>
        <state>Ontario</state>
        <zip>K4A 5E6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <zip>N7T 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 3A9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N8X 5A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mirabel</city>
        <state>Quebec</state>
        <zip>J7J 2K8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sainte Jerome</city>
        <state>Quebec</state>
        <zip>J7Z 5T3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quebec</city>
        <zip>G1G 4A2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Temuco</city>
        <state>Regin De La Araucania</state>
        <zip>4800798</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Temuco</city>
        <state>Regin De La Araucania</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santiago</city>
        <state>Regin Metro De Santiago</state>
        <zip>7500691</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santiago</city>
        <state>Regin Metro De Santiago</state>
        <zip>8910131</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santiago</city>
        <state>Regin Metro De Santiago</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Via del Mar</city>
        <state>Valparaso</state>
        <zip>2340000</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zhanjiang</city>
        <state>Guangdong</state>
        <zip>524001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570311</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hohhot</city>
        <state>Hainan</state>
        <zip>010050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Baotou</city>
        <state>Inner Mongolia</state>
        <zip>014010</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Xian</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610083</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Baotou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beijing</city>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beijing</city>
        <zip>100070</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beijing</city>
        <zip>100144</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bengbu</city>
        <zip>233000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Changchun</city>
        <zip>130012</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chengdu</city>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chongqing</city>
        <zip>400016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chongqing</city>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chongqing</city>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fu Zhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fuzhou</city>
        <zip>350025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guangxi</city>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hangzhou</city>
        <zip>310014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hefei</city>
        <zip>230001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Huai'an</city>
        <zip>223300</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jiangyin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Luzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nanchang</city>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nanjing</city>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>ShangHai</city>
        <zip>200062</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tianjin</city>
        <zip>300121</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wuxi</city>
        <zip>214023</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bogota</city>
        <zip>111211</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bogot</city>
        <zip>80CO</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bogot</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cali</city>
        <zip>571</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Medellin</city>
        <zip>80372</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zipaquira</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cakovec</city>
        <zip>40000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Draganic</city>
        <zip>47201</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hrasce Turopoljsko</city>
        <zip>10020</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hreljin</city>
        <zip>51226</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ivankovo</city>
        <zip>32281</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Karlovac</city>
        <zip>47000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Klenovnik</city>
        <zip>42244</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krapina</city>
        <zip>49000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kutina</city>
        <zip>44320</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novi Marof</city>
        <zip>42220</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Osijek</city>
        <zip>31000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Retkovci</city>
        <zip>32282</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rijeka</city>
        <zip>51000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Samobor</city>
        <zip>10430</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Senj</city>
        <zip>53270</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sibenik</city>
        <zip>22000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sisak</city>
        <zip>44000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Split</city>
        <zip>21000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Strmec Samoborski</city>
        <zip>10434</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Stubicke toplice</city>
        <zip>49244</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sukosan</city>
        <zip>23206</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Varazdin</city>
        <zip>42000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zabok</city>
        <zip>49210</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zadar</city>
        <zip>23000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Benesov</city>
        <zip>256 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beroun</city>
        <zip>266 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brno</city>
        <zip>612 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Havlickuv brod</city>
        <zip>580 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hlucin</city>
        <zip>748 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Holesov</city>
        <zip>769 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jaromer</city>
        <zip>551 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jindrichuv Hradec</city>
        <zip>377 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kolin</city>
        <zip>280 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kralupy nad Vltavou</city>
        <zip>278 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kromeriz</city>
        <zip>767 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Liberec</city>
        <zip>460 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Melnik</city>
        <zip>276 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moravsky Krumlov</city>
        <zip>672 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Neratovice</city>
        <zip>277 11</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novy Jicin</city>
        <zip>741 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ostrava - Belsky les</city>
        <zip>700 30</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ostrava - Poruba</city>
        <zip>70868</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ostrava</city>
        <zip>72880</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plzen</city>
        <zip>301 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plzen</city>
        <zip>323 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 13</city>
        <zip>158 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 17</city>
        <zip>163 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 1</city>
        <zip>110 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 3</city>
        <zip>130 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 4</city>
        <zip>140 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 4</city>
        <zip>140 46</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 5</city>
        <zip>150 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Praha 6</city>
        <zip>169 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rokycany</city>
        <zip>337 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rudna</city>
        <zip>252 19</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Strakonice</city>
        <zip>386 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Strakonice</city>
        <zip>386 29</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Svitavy</city>
        <zip>568 25</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tremosna</city>
        <zip>330 11</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Usti Nad Labem - Klise</city>
        <zip>400 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zatec</city>
        <zip>438 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ferolles Attilly</city>
        <zip>77150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Paris Cedex 04</city>
        <zip>75181</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tarbes</city>
        <zip>65013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Toulouse cedex 9</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Batumi</city>
        <zip>6000</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gurjaani</city>
        <zip>1500</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kutaisi</city>
        <zip>1600</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kvemo Kartli</city>
        <zip>3000</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0101</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0102</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0114</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0141</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0144</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0160</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0177</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0186</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <zip>0191</zip>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bruchsal</city>
        <state>Baden-Wuerttemberg</state>
        <zip>76646</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Deggingen</city>
        <state>Baden-Wuerttemberg</state>
        <zip>73326</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ettlingen</city>
        <state>Baden-Wuerttemberg</state>
        <zip>76275</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Frankfurt</city>
        <state>Baden-Wuerttemberg</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Wuerttemberg</state>
        <zip>76227</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aschaffenburg</city>
        <state>Bayern</state>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Augsburg</city>
        <state>Bayern</state>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Augsburg</city>
        <state>Bayern</state>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bad Woerrishofen</city>
        <state>Bayern</state>
        <zip>86825</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Feldkirchen</city>
        <state>Bayern</state>
        <zip>83620</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fuerth</city>
        <state>Bayern</state>
        <zip>90762</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gauting</city>
        <state>Bayern</state>
        <zip>82131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hoechstadt</city>
        <state>Bayern</state>
        <zip>91315</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Landsberg</city>
        <state>Bayern</state>
        <zip>86899</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <zip>80335</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vilshofen</city>
        <state>Bayern</state>
        <zip>94474</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Weissenhorn</city>
        <state>Bayern</state>
        <zip>89264</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cottbus</city>
        <state>Brandenburg</state>
        <zip>03050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Potsdam</city>
        <state>Brandenburg</state>
        <zip>14478</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ruedersdorf</city>
        <state>Brandenburg</state>
        <zip>15562</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bensheim</city>
        <state>Hessen</state>
        <zip>64625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Darmstadt</city>
        <state>Hessen</state>
        <zip>64287</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kassel</city>
        <state>Hessen</state>
        <zip>34121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Goettingen</city>
        <state>Niedersachsen</state>
        <zip>37081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30159</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Papenburg</city>
        <state>Niedersachsen</state>
        <zip>26871</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Stuhr</city>
        <state>Niedersachsen</state>
        <zip>28816</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wardenburg</city>
        <state>Niedersachsen</state>
        <zip>26203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bergisch Gladbach</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51429</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53119</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53123</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dortmund</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44263</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dueren</city>
        <state>Nordrhein-Westfalen</state>
        <zip>52349</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gelsenkirchen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45879</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hagen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>58089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hagen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>58095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Harsewinkel</city>
        <state>Nordrhein-Westfalen</state>
        <zip>33428</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Koeln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Neuss</city>
        <state>Nordrhein-Westfalen</state>
        <zip>41462</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Solingen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>42651</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Foehren</city>
        <state>Rheinland-Pfalz</state>
        <zip>54343</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ingelheim</city>
        <state>Rheinland-Pfalz</state>
        <zip>55218</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland-Pfalz</state>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Neuwied</city>
        <state>Rheinland-Pfalz</state>
        <zip>56564</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rhaunen</city>
        <state>Rheinland-Pfalz</state>
        <zip>55624</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Magdeburg</city>
        <state>Sachsen-Anhalt</state>
        <zip>39104</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zerbst</city>
        <state>Sachsen-Anhalt</state>
        <zip>39261</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Goerlitz</city>
        <state>Sachsen</state>
        <zip>02826</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leipzg</city>
        <state>Sachsen</state>
        <zip>04109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04157</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04275</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04357</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riesa</city>
        <state>Sachsen</state>
        <zip>01587</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Reinfeld</city>
        <state>Schleswig-Holstein</state>
        <zip>23858</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Schleswig</city>
        <state>Schleswig-Holstein</state>
        <zip>24837</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jena</city>
        <state>Thueringen</state>
        <zip>07740</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>10717</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>10787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>10789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>10969</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12165</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>12687</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>13086</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>13156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Berlin</city>
        <zip>13507</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22291</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mnchen</city>
        <zip>81677</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Athens</city>
        <zip>15126</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Thessaloniki</city>
        <zip>57010</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Balassagyarmat</city>
        <zip>2660</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1101</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1117</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1125</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1191</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Budapest</city>
        <zip>1204</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Debrecen</city>
        <zip>4026</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Debrecen</city>
        <zip>4031</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gyula</city>
        <zip>5703</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kaposvr</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Komarom</city>
        <zip>2900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Koml</city>
        <zip>7300</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mosonmagyarvr</city>
        <zip>9200</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nagykanizsa</city>
        <zip>8800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pcs</city>
        <zip>7635</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sopron</city>
        <zip>9400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Szigetszentmiklos</city>
        <zip>2310</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sziksz</city>
        <zip>H-3800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Szombathely</city>
        <zip>9700</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tatabanya</city>
        <zip>2800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vasarosnameny</city>
        <zip>4800</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <zip>380007</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <zip>380052</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Alappuzha</city>
        <zip>688524</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Angamaly</city>
        <zip>683 572</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aurangabad</city>
        <zip>431001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <zip>560 010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <zip>560 054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <zip>560034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangalore</city>
        <zip>560076</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chennai</city>
        <zip>600034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chennai</city>
        <zip>600100</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guntur</city>
        <zip>522001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <zip>500004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <zip>500035</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <zip>500038</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <zip>302006</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <zip>302022</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lucknow</city>
        <zip>226018</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mysore</city>
        <zip>570002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mysore</city>
        <zip>570004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nagpur</city>
        <zip>440012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nagpur</city>
        <zip>440019</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nashik</city>
        <zip>422007</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nasik</city>
        <zip>422005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pune</city>
        <zip>411014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pune</city>
        <zip>411015</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Trisshur</city>
        <zip>680 002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Trivandrum</city>
        <zip>695004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Varanasi</city>
        <zip>221001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Varanasi</city>
        <zip>221005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vijayawada</city>
        <zip>520002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Banda Aceh</city>
        <zip>23126</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Banjarmasin</city>
        <zip>70233</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bukittinggi</city>
        <zip>26117</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Denpasar</city>
        <zip>80114</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Depok Timur</city>
        <zip>16411</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jakarta</city>
        <zip>12430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jakarta</city>
        <zip>13230</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jakarta</city>
        <zip>13630</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lampung Selatan</city>
        <zip>35373</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Makassar</city>
        <zip>90245</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Malang</city>
        <zip>65100</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Medan</city>
        <zip>20111</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Medan</city>
        <zip>20154</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Padang</city>
        <zip>25127</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Palembang</city>
        <zip>30126</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pekanbaru</city>
        <zip>28133</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pontianak</city>
        <zip>78122</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pringsewu</city>
        <zip>35373</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Semarang</city>
        <zip>50242</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Surabaya</city>
        <zip>60286</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Surakarta</city>
        <zip>57126</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yogyakarta</city>
        <zip>55283</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ashkelon</city>
        <zip>78306</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Beer-Sheba</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hadera</city>
        <zip>PO Box 169</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Haifa</city>
        <zip>34362</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Holon</city>
        <zip>68125</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kfar Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rehovot</city>
        <zip>76100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pordenone</city>
        <state>Friuli-Venezia-Giulia</state>
        <zip>33170</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aichi</city>
        <zip>454-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aichi</city>
        <zip>457-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aichi</city>
        <zip>457-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Fukuoka</city>
        <zip>832-0059</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gifu</city>
        <zip>500-8717</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hokkaido</city>
        <zip>053-8506</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hokkaido</city>
        <zip>060-0033</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hokkaido</city>
        <zip>070-8644</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hyogo</city>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ibaraki</city>
        <zip>319-1113</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kagawa</city>
        <zip>762-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kodaira</city>
        <zip>187-0002</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kumamoto</city>
        <zip>861-1196</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyoto</city>
        <zip>607-8062</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oita</city>
        <zip>876-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Osaka</city>
        <zip>530-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Osaka</city>
        <zip>558-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Osaka</city>
        <zip>591-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shimane</city>
        <zip>690-8509</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shimane</city>
        <zip>690-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tokyo</city>
        <zip>103-0027</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tokyo</city>
        <zip>103-0028</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tokyo</city>
        <zip>194-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucheon-Si, Gyeonggi-Do</city>
        <zip>420-021</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucheon</city>
        <zip>420-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Busan</city>
        <zip>602-715</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cheonan</city>
        <zip>330-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chonju-si</city>
        <zip>561-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daegu</city>
        <zip>705-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daejeon</city>
        <zip>301-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daejeon</city>
        <zip>301-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Goyang-si</city>
        <zip>411706</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guri-si</city>
        <zip>471-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gwangju</city>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gyeonggi-do</city>
        <zip>410-719</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Incheon</city>
        <zip>400-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Incheon</city>
        <zip>403-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kangwon</city>
        <zip>200-722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seongnam</city>
        <zip>463-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>100-030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>110-746</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>130-709</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>130-872</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>133--792</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>135-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>139-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>139-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>140-887</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>150-713</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>158-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <zip>380-704</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Suwon, Gyeonggi-do</city>
        <zip>442-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Uijeongbu, Gyeonggi-do</city>
        <zip>480-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ulsan</city>
        <zip>682-714</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wonju-si, Kanwon-do</city>
        <zip>220-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Balvi</city>
        <zip>LV - 4501</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daugavpils</city>
        <zip>LA-5403</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV5410</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jekabpils</city>
        <zip>LV 5201</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jelgava</city>
        <zip>LV - 3001</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jurmala</city>
        <zip>LV-2010</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kraslava</city>
        <zip>LV - 5601</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kuldiga</city>
        <zip>LV - 3301</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Liepaja</city>
        <zip>LV 3414</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ogre</city>
        <zip>LV - 5001</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riga</city>
        <zip>LV 1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riga</city>
        <zip>LV 1003</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riga</city>
        <zip>LV-1010</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riga</city>
        <zip>LV1001</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Riga</city>
        <zip>LV1038</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Talsi</city>
        <zip>LV - 3201</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tukums</city>
        <zip>LV - 3101</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Valmiera</city>
        <zip>LV-4201</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ventspils</city>
        <zip>LV3601</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bitola</city>
        <zip>7000</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gostivar</city>
        <zip>1230</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ohrid</city>
        <zip>6000</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Prilep</city>
        <zip>7500</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Shtip</city>
        <zip>2000</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Skopje</city>
        <zip>1000</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Strumica</city>
        <zip>2400</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Veles</city>
        <zip>1400</zip>
        <country>Macedonia, The Former Yugoslav Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Johor Bahru</city>
        <zip>80100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50590</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kuala Pilah</city>
        <zip>72000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kuching</city>
        <zip>93586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Selangor</city>
        <zip>68100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sibu</city>
        <zip>96000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sungai Petani, Kedah</city>
        <zip>08000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taiping Perak</city>
        <zip>34000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cuautitlan Izcalli</city>
        <state>Estado De Mxico</state>
        <zip>54769</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44500</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zapopan</city>
        <state>Jalisco</state>
        <zip>45040</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Morelia</city>
        <state>Michoacn</state>
        <zip>C.P. 58249</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cuernavaca</city>
        <state>Morelos</state>
        <zip>62350</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Len</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Len</state>
        <zip>64710</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hermosillo</city>
        <state>Sonora</state>
        <zip>83000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20127</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chihuahua</city>
        <zip>31203</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chihuahua</city>
        <zip>31238</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <zip>44670</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hidalgo</city>
        <zip>42070</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Merida</city>
        <zip>97000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mexico D.F</city>
        <zip>6700</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Monterrey</city>
        <zip>64060</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mxico DF</city>
        <zip>14050</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San luis Potos</city>
        <zip>78090</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815 JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Almelo</city>
        <zip>7609 PP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ede Gld</city>
        <zip>6717RP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Helmond</city>
        <zip>5707 HA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zutphen</city>
        <zip>7207 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Alabang, Muntinlupa City</city>
        <zip>1780</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Caloocan</city>
        <zip>1400</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cavite</city>
        <zip>4114</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cebu City</city>
        <zip>6000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dasmarias, Cavite</city>
        <zip>4114</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Davao</city>
        <zip>8000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iloilo City</city>
        <zip>5000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iloilo</city>
        <zip>5000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jaro, Iloilo City</city>
        <zip>5000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Los Banos</city>
        <zip>4030</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Manila</city>
        <zip>1000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Manila</city>
        <zip>1012</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Marilao, Bulacan</city>
        <zip>3019</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pasay</city>
        <zip>1300</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pasig</city>
        <zip>1605</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quezon City</city>
        <zip>1100</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quezon City</city>
        <zip>1102</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quezon City</city>
        <zip>1108</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quezon City</city>
        <zip>1109</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Quezon</city>
        <zip>1104</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>San Fernando, Pampanga</city>
        <zip>2000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bialystok</city>
        <zip>15-003</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bialystok</city>
        <zip>15-044</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bielsko-Biala</city>
        <zip>43-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bielsko-Biala</city>
        <zip>43-316</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bienkowka</city>
        <zip>34-212</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-681</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-863</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chelmza</city>
        <zip>87-140</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chodziez</city>
        <zip>64-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chorzow</city>
        <zip>41-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Choszczno</city>
        <zip>73-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Czestochowa</city>
        <zip>42-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dabrowa Gornicza</city>
        <zip>41-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dzialdowo</city>
        <zip>13-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Elblag</city>
        <zip>82-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-286</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-405</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-433</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gdynia</city>
        <zip>81-384</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gorzow Wielkopolski</city>
        <zip>66-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Grudziadz</city>
        <zip>86-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ilawa</city>
        <zip>14-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Inowroclaw</city>
        <zip>88-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Izabelin</city>
        <zip>05-080</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jelenia Gora</city>
        <zip>58-506</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Karpacz</city>
        <zip>58-540</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Katowice</city>
        <zip>40-040</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Katowice</city>
        <zip>40-954</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kielce</city>
        <zip>25-030</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kielce</city>
        <zip>25-365</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kielce</city>
        <zip>25-734</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-024</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-455</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-530</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-567</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-637</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krakow</city>
        <zip>31-913</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krotoszyn</city>
        <zip>63-700</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ksawerow</city>
        <zip>95-054</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kutno</city>
        <zip>99-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Libiaz</city>
        <zip>32-590</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>90-153</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>90-203</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>90-302</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>90-430</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>91-849</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>92-107</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>92-215</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>93-113</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>93-329</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lodz</city>
        <zip>94-050</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lublin</city>
        <zip>20-093</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lublin</city>
        <zip>20-552</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lublin</city>
        <zip>20-718</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Olawa</city>
        <zip>55-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-357</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ostrow Wilekopolski</city>
        <zip>63-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ostrowiec Swietokrzyski</city>
        <zip>27-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Piaseczno</city>
        <zip>05-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pila</city>
        <zip>64-920</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Plock</city>
        <zip>09-402</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Police</city>
        <zip>72-010</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-214</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-569</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-773</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poznan</city>
        <zip>60-823</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ruda Slaska</city>
        <zip>41-709</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rudka</city>
        <zip>05-320</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rzeszow</city>
        <zip>35-301</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Skarzysko-Kamienna</city>
        <zip>26-110</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Skierniewice</city>
        <zip>96-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Slupsk</city>
        <zip>76-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sopot</city>
        <zip>81- 717</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Swidnik</city>
        <zip>21-040</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Szczecin</city>
        <zip>71-124</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tarnow</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tczew</city>
        <zip>83-110</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Torun</city>
        <zip>87100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>01-138</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>01-157</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>01-192</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <zip>01-868</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wloclawek</city>
        <zip>87-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wloszczowa</city>
        <zip>29-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wodzislaw Slaski</city>
        <zip>44-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-044</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-088</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>53-301</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>53-439</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>54-239</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zabrze</city>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zabrze</city>
        <zip>41-807</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zgierz</city>
        <zip>95-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>czyca</city>
        <zip>99-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Arad</city>
        <zip>310013</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bacau</city>
        <zip>600252</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bragadiru</city>
        <zip>077025</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brasov</city>
        <zip>500086</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brasov</city>
        <zip>500283</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucarest</city>
        <zip>050159</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <zip>011794</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <zip>030303</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <zip>050159</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>011025</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>012384</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>014461</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>020475</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>021659</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>030303</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>040206</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>050159</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>050554</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>050722</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <zip>10825</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Campulung Muscel</city>
        <zip>115100</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400352</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400371</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Codlea</city>
        <zip>505100</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Constanta</city>
        <zip>900002</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Constanta</city>
        <zip>900004</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Deva</city>
        <zip>330084</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iasi</city>
        <zip>700141</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iasi</city>
        <zip>700381</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iasi</city>
        <zip>700503</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Iasi</city>
        <zip>700656</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pitesti</city>
        <zip>110084</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pitesti</city>
        <zip>110283</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ploiesti</city>
        <zip>100184</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ramnicu Valcea</city>
        <zip>240564</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Suceava</city>
        <zip>720284</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Targu-Mures</city>
        <zip>540142</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300310</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Arkhangelsk</city>
        <zip>163001</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Arkhangelsk</city>
        <zip>163061</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barnaul</city>
        <zip>656024</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barnaul</city>
        <zip>656038</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454091</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620109</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620137</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620149</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gatchina</city>
        <zip>188300</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ivanovo</city>
        <zip>153462</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Izhevsk</city>
        <zip>426063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kaliningrad</city>
        <zip>236016</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kazan</city>
        <zip>420012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <zip>650000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kirov</city>
        <zip>610027</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Krasnoyarsk</city>
        <zip>660022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kursk</city>
        <zip>305035</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>105066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>107392</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>109263</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>111111</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115 280</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115093</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115432</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115478</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115516</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>115682</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>117292</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>117593</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>117630</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>117997</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119048</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119049</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119121</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119229</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119620</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>121 309</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>121374</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>123060</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>123182</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>125205</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>125299</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>127018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>129090</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Moscow</city>
        <zip>129301</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nizhniy Novgorod</city>
        <zip>603035</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630008</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630051</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630075</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630091</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630099</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orenburg</city>
        <zip>460000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Orenburg</city>
        <zip>460018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Perm</city>
        <zip>614070</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Perm</city>
        <zip>614097</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Perm</city>
        <zip>614111</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pskov</city>
        <zip>180016</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ryazan</city>
        <zip>390005</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ryazan</city>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ryazan</city>
        <zip>390039</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192177</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>194044</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>195257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196084</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>198103</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>195112</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>196084</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>196601</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>198260</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>198328</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410039</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Saratov</city>
        <zip>410054</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sestroretsk</city>
        <zip>197706</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Smolensk</city>
        <zip>214 019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Smolensk</city>
        <zip>214006</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St Petersburg</city>
        <zip>192283</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St'Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St-Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St-Petersburg</city>
        <zip>194017</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St-Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>190103</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>191015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>194356</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St.Petersburg</city>
        <zip>191025</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St.Petersburg</city>
        <zip>197089</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>St.etersburg</city>
        <zip>198035</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <zip>634 050</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <zip>634012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <zip>634050</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <zip>634063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tver</city>
        <zip>170036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ufa</city>
        <zip>450071</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ulyanovsk</city>
        <zip>432063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Voronezh</city>
        <zip>394018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Voronezh</city>
        <zip>394066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vsevolzhsk</city>
        <zip>188640</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150010</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150023</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cacak</city>
        <zip>32000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sombor</city>
        <zip>25000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sremska Kamenica</city>
        <zip>21204</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Valjevo</city>
        <zip>14000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <zip>821 06</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <zip>841 04</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <zip>841 08</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <zip>851 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kosice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kralovsky Chlmec</city>
        <zip>077 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nove Zamky</city>
        <zip>940 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Presov</city>
        <zip>080 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Presov</city>
        <zip>081 81</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Spisska Nova Ves</city>
        <zip>052 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sturovo</city>
        <zip>943 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Trnava</city>
        <zip>917 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vrable</city>
        <zip>952 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Benoni</city>
        <state>Gauteng</state>
        <zip>1501</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Boksburg</city>
        <state>Gauteng</state>
        <zip>1459</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Meyerspark</city>
        <state>Gauteng</state>
        <zip>0184</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Morningside</city>
        <state>Gauteng</state>
        <zip>2057</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0041</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0084</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0181</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0183</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Thaba Tshwane</city>
        <state>Gauteng</state>
        <zip>0143</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dundee</city>
        <state>KwaZulu- Natal</state>
        <zip>3000</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Middelburg</city>
        <state>Mpumalanga</state>
        <zip>1055</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Benoni</city>
        <zip>1501</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bloemfontein</city>
        <zip>9301</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7441</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7572</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <zip>7700</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <zip>8001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>CapeTown</city>
        <zip>7764</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Durban</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Durban</city>
        <zip>4071</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Gatesville</city>
        <zip>7764</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <zip>1686</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Korsten</city>
        <zip>6014</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lynnwood Ridge</city>
        <zip>0014</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mowbray</city>
        <zip>7700</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Paarl</city>
        <zip>7646</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Panorama</city>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Potchefstroom</city>
        <zip>2531</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <zip>0002</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <zip>0022</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Roodepoort</city>
        <zip>1724</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Rooihuiskraal</city>
        <zip>158</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Somerset West</city>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Thabazimbi</city>
        <zip>0380</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tygerberg</city>
        <zip>7505</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Voorspoed</city>
        <zip>9459</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <zip>08022</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Benidorm</city>
        <zip>03501</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Canet De Mar - Barcelona</city>
        <zip>08360</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Galdakano</city>
        <zip>48960</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Illescas-Toledo</city>
        <zip>45200</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Jerez de la Frontera</city>
        <zip>11407</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Matar</city>
        <zip>08303</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Oviedo</city>
        <zip>33006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Palma de Mallorca</city>
        <zip>07010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Pozuelo De Alarcn/Madrid</city>
        <zip>28223</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sabadell (Barcelona)</city>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sagunto/Valencia</city>
        <zip>46520</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sant Boi de Llobregat</city>
        <zip>08830</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santa Coloma de Gramenet</city>
        <zip>08921</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Santiago de Compostela</city>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Torrelavega</city>
        <zip>39300</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Valencia</city>
        <zip>46017</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vic (Barcelona)</city>
        <zip>08500</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Changhua</city>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chia-Yi</city>
        <zip>613</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kaohsiung Hsien</city>
        <zip>833</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Keelung</city>
        <zip>20401</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>LinKou</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taichung</city>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taichung</city>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taichung</city>
        <zip>40705</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taichung</city>
        <zip>433</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taichung</city>
        <zip>437</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tainan</city>
        <zip>704</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taipei</city>
        <zip>106</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taipei</city>
        <zip>115</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taipei</city>
        <zip>220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taipei</city>
        <zip>235</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yung Kang City</city>
        <zip>71044</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10220</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10600</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chiangmai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chiangrai</city>
        <zip>57000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mae Rim, Chiang Mai</city>
        <zip>50180</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Muang Phitsanulok</city>
        <zip>53000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Muang</city>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Nakhon Ratchasima</city>
        <zip>30000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Phitsanulok</city>
        <zip>65000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Songkla</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>06280</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>06500</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>06510</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>06590</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ankara</city>
        <zip>6030</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bursa</city>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34020</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>stanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34844</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34899</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <zip>61080</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kocaeli</city>
        <zip>41380</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Konya</city>
        <zip>42080</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Samsun</city>
        <zip>55139</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Alupka</city>
        <zip>98676</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cherkassy</city>
        <zip>18009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chernihiv</city>
        <zip>14034</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chernivtsi</city>
        <zip>58022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49027</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49064</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49074</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49102</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Donetsk</city>
        <zip>83003</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Donetsk</city>
        <zip>83045</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Donetsk</city>
        <zip>83059</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Donetsk</city>
        <zip>83114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76008</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61002</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61046</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61103</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61124</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <zip>61157</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kherson</city>
        <zip>73000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kiev</city>
        <zip>02660</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kiev</city>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kryvyi Rig</city>
        <zip>50096</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>03038</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>03049</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>03179</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>04114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>04201</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>1680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>4050</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kyiv</city>
        <zip>4107</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lutsk</city>
        <zip>43024</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lviv</city>
        <zip>79010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Lviv</city>
        <zip>79015</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Mykolaiv</city>
        <zip>54003</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Odesa</city>
        <zip>65010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Odesa</city>
        <zip>65114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Odessa</city>
        <zip>65009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Odessa</city>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poltava</city>
        <zip>36024</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poltava</city>
        <zip>36028</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Poltava</city>
        <zip>36038</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Simferopol</city>
        <zip>95043</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sumy</city>
        <zip>40022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sumy</city>
        <zip>40030</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sympheropol</city>
        <zip>95017</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ternopil</city>
        <zip>46002</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Uzhhorod</city>
        <zip>88000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Uzhhorod</city>
        <zip>88009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Uzhhorod</city>
        <zip>88017</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Vinnytsya</city>
        <zip>21001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Yalta</city>
        <zip>98603</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhia</city>
        <zip>69035</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69106</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69118</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69600</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zaporizhzhya</city>
        <zip>69001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Zhytomyr</city>
        <zip>10002</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bedford</city>
        <state>Bedfordshire</state>
        <zip>MK404AW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bedford</city>
        <state>Bedfordshire</state>
        <zip>MK42 9DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Peterborough</city>
        <state>Cambridgeshire</state>
        <zip>PE8 6PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Soham</city>
        <state>Cambridgeshire</state>
        <zip>CB7 5JD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <state>Derbyshire</state>
        <zip>S40 4AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Buckshaw Village, Chorley</city>
        <state>Lancashire</state>
        <zip>PR7 7NA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Liverpool</city>
        <state>Merseyside</state>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Waterloo, Liverpool</city>
        <state>Merseyside</state>
        <zip>L22 0LG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Northwood</city>
        <state>Middlesex</state>
        <zip>HA6 2RN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bury St Edmunds</city>
        <state>Suffolk</state>
        <zip>IP30 9QU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bexhill-on-Sea</city>
        <zip>TN40 1JJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Brighton</city>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 5GJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Chelmsford</city>
        <zip>CM1 7ET</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edgbaston, Birmingham</city>
        <zip>B15 2SQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Glasgow</city>
        <zip>G20 0SP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>London</city>
        <zip>EC1M 6BQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Manchester</city>
        <zip>M15 6SX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Milton Keynes</city>
        <zip>MK6 5LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Reading</city>
        <zip>RG2 0TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Sidcup, Kent</city>
        <zip>DA14 6LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Tyne And Wear</city>
        <zip>NE29 8NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Can Tho</city>
        <zip>90000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ha Noi</city>
        <zip>10000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Ho Chi Minh</city>
        <zip>70000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hue</city>
        <zip>53000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belarus</country>
    <country>Belgium</country>
    <country>Bosnia and Herzegovina</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Georgia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Indonesia</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Latvia</country>
    <country>Macedonia, The Former Yugoslav Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
    <country>Vietnam</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>https://www.clinicalstudydatarequest.com</url>
    <description>Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2011</study_first_submitted>
  <study_first_submitted_qc>March 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2011</study_first_posted>
  <results_first_submitted>March 10, 2016</results_first_submitted>
  <results_first_submitted_qc>June 29, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 9, 2016</results_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Novel Dry Powder Inhaler</keyword>
  <keyword>Survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluticasone</mesh_term>
  </intervention_browse>
  <study_docs>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Statistical Analysis Plan</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Annotated Case Report Form</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Dataset Specification</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>113782</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>https://www.clinicalstudydatarequest.com</doc_url>
      <doc_comment>For additional information about this study please refer to the GSK Clinical Study Register</doc_comment>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study was conducted at 1373 sites. The study employed an event-driven design and was to conclude when approximately 1000 reports of a primary outcome event of death were received. The study consisted of a 4-10 day run-in period, variable treatment period until the required number of events was achieved, and 1 week follow-up period.</recruitment_details>
      <pre_assignment_details>A total of 23,835 participants were screened, of whom 16,590 were randomized. Of the 16,590 participants randomized, 16,568 participants received a single dose of investigational product (IP) and were assigned to a treatment and included in the Safety Population.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Participants received placebo once daily (OD) in the morning from the dry powder inhaler (DPI) until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="P2">
          <title>Fluticasone Furoate 100 g</title>
          <description>Participants received Fluticasone Furoate (FF) 100 microgram (g) inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="P3">
          <title>Vilanterol 25 g</title>
          <description>Participants received Vilanterol (VI) 25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="P4">
          <title>Fluticasone Furoate/Vilanterol 100/25 g</title>
          <description>Participants received FF/VI 100/25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4131"/>
                <participants group_id="P2" count="4157"/>
                <participants group_id="P3" count="4140"/>
                <participants group_id="P4" count="4140"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2881"/>
                <participants group_id="P2" count="3044"/>
                <participants group_id="P3" count="3052"/>
                <participants group_id="P4" count="3146"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1250"/>
                <participants group_id="P2" count="1113"/>
                <participants group_id="P3" count="1088"/>
                <participants group_id="P4" count="994"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="395"/>
                <participants group_id="P2" count="365"/>
                <participants group_id="P3" count="372"/>
                <participants group_id="P4" count="333"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="98"/>
                <participants group_id="P2" count="90"/>
                <participants group_id="P3" count="65"/>
                <participants group_id="P4" count="46"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="46"/>
                <participants group_id="P4" count="44"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Met Protocol-Defined Stopping Critera</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study Closed/terminated</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="9"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="64"/>
                <participants group_id="P3" count="62"/>
                <participants group_id="P4" count="48"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Decision by Participant or Proxy</title>
              <participants_list>
                <participants group_id="P1" count="643"/>
                <participants group_id="P2" count="527"/>
                <participants group_id="P3" count="515"/>
                <participants group_id="P4" count="492"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor Terminated Study Treatment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Investigator Site Closed</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Participants received placebo once daily (OD) in the morning from the dry powder inhaler (DPI) until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="B2">
          <title>Fluticasone Furoate 100 g</title>
          <description>Participants received Fluticasone Furoate (FF) 100 microgram (g) inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="B3">
          <title>Vilanterol 25 g</title>
          <description>Participants received Vilanterol (VI) 25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="B4">
          <title>Fluticasone Furoate/Vilanterol 100/25 g</title>
          <description>Participants received FF/VI 100/25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4131"/>
            <count group_id="B2" value="4157"/>
            <count group_id="B3" value="4140"/>
            <count group_id="B4" value="4140"/>
            <count group_id="B5" value="16568"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.2" spread="7.90"/>
                    <measurement group_id="B2" value="65.0" spread="8.02"/>
                    <measurement group_id="B3" value="65.2" spread="7.68"/>
                    <measurement group_id="B4" value="65.3" spread="7.97"/>
                    <measurement group_id="B5" value="65.2" spread="7.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1050"/>
                    <measurement group_id="B2" value="1098"/>
                    <measurement group_id="B3" value="1071"/>
                    <measurement group_id="B4" value="1019"/>
                    <measurement group_id="B5" value="4238"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3081"/>
                    <measurement group_id="B2" value="3059"/>
                    <measurement group_id="B3" value="3069"/>
                    <measurement group_id="B4" value="3121"/>
                    <measurement group_id="B5" value="12330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>African American /African Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="69"/>
                    <measurement group_id="B5" value="260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaskan Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian - Central /South Asian Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="57"/>
                    <measurement group_id="B5" value="238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian - East Asian Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="192"/>
                    <measurement group_id="B2" value="193"/>
                    <measurement group_id="B3" value="195"/>
                    <measurement group_id="B4" value="192"/>
                    <measurement group_id="B5" value="772"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian - Japanese Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian - Mixed Race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian - South East Asian Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="389"/>
                    <measurement group_id="B2" value="399"/>
                    <measurement group_id="B3" value="386"/>
                    <measurement group_id="B4" value="394"/>
                    <measurement group_id="B5" value="1568"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White - Arabic/North African Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White - Mixed Race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White - White/Caucasian /European Heritage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3334"/>
                    <measurement group_id="B2" value="3367"/>
                    <measurement group_id="B3" value="3353"/>
                    <measurement group_id="B4" value="3337"/>
                    <measurement group_id="B5" value="13391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mixed Race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Death (Both on and Off Treatment) Due to Any Cause, Time up to or on the Pre-determined Common End Date</title>
        <description>Death from any cause: which occurred from the day of starting IP until the Commone End Date (CED). Common End Date (CED) is the study end date that was pre determined where approximately 1000 deaths would have occurred in the Intent-toTreat Efficacy (ITT-E) Population. Only deaths which occurred on or before the CED were used for the primary analysis. Those who had not died by CED, but who were known to be alive on or after the CED, were censored at the CED. Cox Proportional Hazards (PH) Model was adjusted for age, and gender, including all 4 arms. A hazard ratio of less than 1 indicates a lower death rate versus placebo or other arm. ITT-E Population consisted of all participants in the Safety Population (i.e. randomized to IP and who received at least one dose of IP), with the exception of those recruited at sites that were closed.</description>
        <time_frame>From the date of randomization until date of death due to any cause (average of 2 study years)</time_frame>
        <population>ITT-E Population</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received placebo once daily (OD) in the morning from the dry powder inhaler (DPI) until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O2">
            <title>Fluticasone Furoate 100 g</title>
            <description>Participants received Fluticasone Furoate (FF) 100 microgram (g) inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O3">
            <title>Vilanterol 25 g</title>
            <description>Participants received Vilanterol (VI) 25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O4">
            <title>Fluticasone Furoate/Vilanterol 100/25 g</title>
            <description>Participants received FF/VI 100/25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Death (Both on and Off Treatment) Due to Any Cause, Time up to or on the Pre-determined Common End Date</title>
          <description>Death from any cause: which occurred from the day of starting IP until the Commone End Date (CED). Common End Date (CED) is the study end date that was pre determined where approximately 1000 deaths would have occurred in the Intent-toTreat Efficacy (ITT-E) Population. Only deaths which occurred on or before the CED were used for the primary analysis. Those who had not died by CED, but who were known to be alive on or after the CED, were censored at the CED. Cox Proportional Hazards (PH) Model was adjusted for age, and gender, including all 4 arms. A hazard ratio of less than 1 indicates a lower death rate versus placebo or other arm. ITT-E Population consisted of all participants in the Safety Population (i.e. randomized to IP and who received at least one dose of IP), with the exception of those recruited at sites that were closed.</description>
          <population>ITT-E Population</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4111"/>
                <count group_id="O2" value="4135"/>
                <count group_id="O3" value="4118"/>
                <count group_id="O4" value="4121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dead</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="275"/>
                    <measurement group_id="O2" value="251"/>
                    <measurement group_id="O3" value="265"/>
                    <measurement group_id="O4" value="246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alive</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3832"/>
                    <measurement group_id="O2" value="3884"/>
                    <measurement group_id="O3" value="3853"/>
                    <measurement group_id="O4" value="3874"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.137</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.878</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.739</ci_lower_limit>
            <ci_upper_limit>1.042</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>12.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.2</ci_lower_limit>
            <ci_upper_limit>26.1</ci_upper_limit>
            <estimate_desc>Confidence Interval (95%) and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.284</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.911</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.767</ci_lower_limit>
            <ci_upper_limit>1.081</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>8.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.1</ci_lower_limit>
            <ci_upper_limit>23.3</ci_upper_limit>
            <estimate_desc>Confidence Interval (95%) and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.655</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.962</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.813</ci_lower_limit>
            <ci_upper_limit>1.139</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>3.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.9</ci_lower_limit>
            <ci_upper_limit>18.7</ci_upper_limit>
            <estimate_desc>Confidence Interval (95%) and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.681</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.964</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.808</ci_lower_limit>
            <ci_upper_limit>1.149</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-14.9</ci_lower_limit>
            <ci_upper_limit>19.2</ci_upper_limit>
            <estimate_desc>Confidence Interval (95%) and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.299</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.912</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.767</ci_lower_limit>
            <ci_upper_limit>1.085</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>8.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.5</ci_lower_limit>
            <ci_upper_limit>23.3</ci_upper_limit>
            <estimate_desc>Confidence Interval (95%) and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Decline in Forced Expiratory Volume in 1 Second (FEV1)</title>
        <description>FEV1 is a measure of lung function and is defined as the maximal amount of air that can be forcefully exhaled in one second. The effect of treatment on decline of post bronchodilator FEV1 recorded during the treatment period was analyzed using a particular form of a mixed effect model - a random coefficients model. FEV1 was fitted as the response variable with treatment group, age, gender, baseline FEV1 and time on treatment as fixed effects. Time on treatment was treated as a continuous variable. This model allowed for an initial increase in FEV1, but then tested the difference in slopes from the first post-baseline measurement which was at 3 months. A negative slope indicates a decline. A positive treatment difference indicates a slower rate of decline vs Placebo or Component. Only participants with at least one on-treatment post-bronchodilator FEV1 measurement were analyzed.</description>
        <time_frame>From start date of IP until IP stop date + 1 (assessed up to 4 years)</time_frame>
        <population>ITT-E Population</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received placebo once daily (OD) in the morning from the dry powder inhaler (DPI) until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O2">
            <title>Fluticasone Furoate 100 g</title>
            <description>Participants received Fluticasone Furoate (FF) 100 microgram (g) inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O3">
            <title>Vilanterol 25 g</title>
            <description>Participants received Vilanterol (VI) 25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O4">
            <title>Fluticasone Furoate/Vilanterol 100/25 g</title>
            <description>Participants received FF/VI 100/25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
        </group_list>
        <measure>
          <title>Decline in Forced Expiratory Volume in 1 Second (FEV1)</title>
          <description>FEV1 is a measure of lung function and is defined as the maximal amount of air that can be forcefully exhaled in one second. The effect of treatment on decline of post bronchodilator FEV1 recorded during the treatment period was analyzed using a particular form of a mixed effect model - a random coefficients model. FEV1 was fitted as the response variable with treatment group, age, gender, baseline FEV1 and time on treatment as fixed effects. Time on treatment was treated as a continuous variable. This model allowed for an initial increase in FEV1, but then tested the difference in slopes from the first post-baseline measurement which was at 3 months. A negative slope indicates a decline. A positive treatment difference indicates a slower rate of decline vs Placebo or Component. Only participants with at least one on-treatment post-bronchodilator FEV1 measurement were analyzed.</description>
          <population>ITT-E Population</population>
          <units>milliliter/year</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3800"/>
                <count group_id="O2" value="3879"/>
                <count group_id="O3" value="3866"/>
                <count group_id="O4" value="3912"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-46" spread="2.5"/>
                    <measurement group_id="O2" value="-38" spread="2.4"/>
                    <measurement group_id="O3" value="-47" spread="2.4"/>
                    <measurement group_id="O4" value="-38" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.019</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>8</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1</ci_lower_limit>
            <ci_upper_limit>15</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.026</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>8</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1</ci_lower_limit>
            <ci_upper_limit>14</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.654</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8</ci_lower_limit>
            <ci_upper_limit>5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.913</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6</ci_lower_limit>
            <ci_upper_limit>7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>10</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3</ci_lower_limit>
            <ci_upper_limit>16</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With First On-treatment Cardiovascular (CV) Composite Events Occured on or Before Common End Date</title>
        <description>On-treatment CV composite event is comprised of the first event that is adjudicated as on-treatment CV death, myocardial infarction, stroke, unstable angina, or transient ischemic attack experienced by a participant. The events that occurred no more than 7 days after the participants last dose of IP are considered as on-treatment adverse events. Common end date is the study end date where approximately 1000 deaths would have occurred in the ITT-E Population. Cox PH Model was used to assess time to first on-treatment CV composite event. Cox PH Model was adjusted for age, gender and indicators of ischemic and vascular disease, including all four treatment arms. A hazard ratio less than 1 indicates a lower risk of a first CV event rate versus placebo or any arm.</description>
        <time_frame>From the start of IP to first on treatment CV event till 7 days after the last dose of IP (average of 2 study years)</time_frame>
        <population>ITT-E Population</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received placebo once daily (OD) in the morning from the dry powder inhaler (DPI) until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period</description>
          </group>
          <group group_id="O2">
            <title>Fluticasone Furoate 100 g</title>
            <description>Participants received Fluticasone Furoate (FF) 100 microgram (g) inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O3">
            <title>Vilanterol 25 g</title>
            <description>Participants received Vilanterol (VI) 25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
          <group group_id="O4">
            <title>Fluticasone Furoate/Vilanterol 100/25 g</title>
            <description>Participants received FF/VI 100/25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With First On-treatment Cardiovascular (CV) Composite Events Occured on or Before Common End Date</title>
          <description>On-treatment CV composite event is comprised of the first event that is adjudicated as on-treatment CV death, myocardial infarction, stroke, unstable angina, or transient ischemic attack experienced by a participant. The events that occurred no more than 7 days after the participants last dose of IP are considered as on-treatment adverse events. Common end date is the study end date where approximately 1000 deaths would have occurred in the ITT-E Population. Cox PH Model was used to assess time to first on-treatment CV composite event. Cox PH Model was adjusted for age, gender and indicators of ischemic and vascular disease, including all four treatment arms. A hazard ratio less than 1 indicates a lower risk of a first CV event rate versus placebo or any arm.</description>
          <population>ITT-E Population</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4111"/>
                <count group_id="O2" value="4135"/>
                <count group_id="O3" value="4118"/>
                <count group_id="O4" value="4121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Had CV composite event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                    <measurement group_id="O2" value="161"/>
                    <measurement group_id="O3" value="180"/>
                    <measurement group_id="O4" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No CV composite event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3938"/>
                    <measurement group_id="O2" value="3974"/>
                    <measurement group_id="O3" value="3938"/>
                    <measurement group_id="O4" value="3947"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.475</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.926</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.750</ci_lower_limit>
            <ci_upper_limit>1.143</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of CV event</param_type>
            <param_value>7.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-14.3</ci_lower_limit>
            <ci_upper_limit>25.0</ci_upper_limit>
            <estimate_desc>Confidence Interval and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.317</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.896</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.723</ci_lower_limit>
            <ci_upper_limit>1.111</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of CV event</param_type>
            <param_value>10.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.1</ci_lower_limit>
            <ci_upper_limit>27.7</ci_upper_limit>
            <estimate_desc>Confidence Interval and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.908</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.988</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.802</ci_lower_limit>
            <ci_upper_limit>1.217</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-21.7</ci_lower_limit>
            <ci_upper_limit>19.8</ci_upper_limit>
            <estimate_desc>Confidence Interval and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.763</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.033</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.834</ci_lower_limit>
            <ci_upper_limit>1.281</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>-3.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-28.1</ci_lower_limit>
            <ci_upper_limit>16.6</ci_upper_limit>
            <estimate_desc>Confidence Interval and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.545</p_value>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.938</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.761</ci_lower_limit>
            <ci_upper_limit>1.155</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percent reduction in risk of death</param_type>
            <param_value>6.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-15.5</ci_lower_limit>
            <ci_upper_limit>23.9</ci_upper_limit>
            <estimate_desc>Confidence Interval and Estimated Value is presented for the percent reduction in risk of death at any time up to or on the CED, calculated as (1-hazard ratio)*100</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>On-treatment serious adverse events (SAEs) and non-serious adverse events (AEs) were collected from start of IP until IP discontinuation + 1 day (average of 2 study years).</time_frame>
      <desc>On-treatment SAEs and non-serious AEs are reported for safety population, comprised of all participants randomized to treatment who received at least one dose IP.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Participants received placebo once daily (OD) in the morning from the dry powder inhaler (DPI) until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="E2">
          <title>Fluticasone Furoate 100 g</title>
          <description>Participants received Fluticasone Furoate (FF) 100 microgram (g) inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="E3">
          <title>Vilanterol 25 g</title>
          <description>Participants received Vilanterol (VI) 25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
        <group group_id="E4">
          <title>Fluticasone Furoate/Vilanterol 100/25 g</title>
          <description>Participants received FF/VI 100/25 g inhalation powder OD in the morning from the DPI until the required number of events (death) was achieved. Participants were provided albuterol/salbutamol inhalation aerosol to be used as rescue medication during the Treatment Period.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="918" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="929" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="972" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="961" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Agranulocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bone marrow oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypercoagulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypersplenism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Immune thrombocytopenic purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Splenic vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spontaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thrombocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adams-Stokes syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="30" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="32" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="30" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="24" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary ostial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diastolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Left ventricular hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mitral valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myocardial fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="24" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myocardial necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rheumatic heart disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Supraventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tachycardia paroxysmal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ventricle rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenogenital syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pyloric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sturge-Weber syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vitello-intestinal duct remnant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Addison's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Basedow's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism secondary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Primary hyperaldosteronism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Blindness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Iridodonesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ocular hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ocular ischaemic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Retinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Retinal tear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Retinal vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vitreous prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abdominal incarcerated hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dieulafoy's vascular malformation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Duodenal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Enterocutaneous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Femoral hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastroduodenal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Incarcerated inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Incarcerated umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Inflammatory bowel disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Inguinal hernia strangulated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Large intestinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Noninfective sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oedematous pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oesophagitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatic necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peptic ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peritoneal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peritoneal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Small intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Varices oesophageal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device defective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device deployment issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device electrical finding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Electrocution</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Liver injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Portal hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Post cholecystectomy syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Food allergy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abscess intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Amoebiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atypical mycobacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Biliary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Biliary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Breast abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary aspergillosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholangitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Embolic pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Emphysematous cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gallbladder empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastroenteritis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Graft infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatitis A</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatitis E</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Herpes zoster disseminated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Incision site abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Infected bites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lymph gland infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lymph node abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Meningitis aseptic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Meningoencephalitis herpetic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neuroborreliosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oropharyngeal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Otitis externa bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Periorbital cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pharyngotonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="121" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="90" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="123" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia moraxella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <description>s</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Purulent discharge</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pyelocystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Salmonella sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis septic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Toxic shock syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tuberculous pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Typhoid fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Viral myocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Burns third degree</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cataract traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chemical burn of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chemical injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Comminuted fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coronary vascular graft occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dislocation of vertebra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Exposure via inhalation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Eye contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Failure to anastomose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal anastomosis complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Joint capsule rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Periorbital contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Periprosthetic fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Post laminectomy syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Postoperative hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Postoperative respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Radiation pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Shunt thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sternal fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title vocab="MedDRA c">Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Traumatic haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urethral injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>VIth nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular graft thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Wound evisceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Blood glucose fluctuation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myocardial necrosis marker increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arthrofibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bone lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coccydynia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Fracture nonunion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Systemic lupus erythematosus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Ischaemic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of salivary gland</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Angiomyolipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Astrocytoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of adrenal gland</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of prostate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage I, without cancer in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma stage 0</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Breast cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brenner tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchioloalveolar carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Choroid melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colon cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colon cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ear neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Eyelid haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage III</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stromal tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Head and neck cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Inflammatory pseudotumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Laryngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage I</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage 0</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage III</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lymphangiosis carcinomatosa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lymphocytic lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of ampulla of Vater</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of choroid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mesenteric neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to adrenals</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to bone marrow</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to spleen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastases to stomach</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myeloproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neuroendocrine tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage IIIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage IIIB</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oesophageal squamous cell carcinoma stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oral neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Oropharyngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ovarian cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ovarian germ cell teratoma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ovarian granulosa cell tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Papillary cystadenoma lymphomatosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Phyllodes tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Polycythaemia vera</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal oncocytoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Retroperitoneal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Round cell liposarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Schwannoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Scrotal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal cord neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the cervix</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>T-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Throat cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thymoma malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ureteric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Uterine leiomyosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vocal cord neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vulvar adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Basal ganglia infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Basilar artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain stem ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Brain stem stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carotid arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carotid artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebellar atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebellar syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebral ventricle dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebrospinal fluid leakage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Complex partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhagic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>IIIrd nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Meralgia paraesthetica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Myasthenia gravis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Postictal paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Radicular syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sacral radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spinal cord disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Spondylitic myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thoracic outlet syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Transient global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular parkinsonism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vertebral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Drug abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dysphoria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Psychogenic seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Schizophrenia, paranoid type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Substance abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Substance-induced mood disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Suicidal behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hallucination, visual</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder neck sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bladder stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urethral disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cervix disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Fallopian tube cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peyronie's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Uterine enlargement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchial polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchial secretion retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bronchostenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Bullous lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="262" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="214" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="245" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="189" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Laryngeal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Laryngeal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung consolidation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nasal septum disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Organising pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pharyngeal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pickwickian syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary hilum mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vocal cord disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dermatitis exfoliative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Erythema nodosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Idiopathic angioedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Neuropathic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin maceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin sensitisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Finger amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Rotator cuff repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Aortic thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arterial disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arterial rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Diabetic microangiopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Penetrating atherosclerotic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral circulatory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Poor peripheral circulation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Raynaud's phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Renovascular hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Secondary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Subclavian artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Subclavian steal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thromboangiitis obliterans</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vascular stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vasoconstriction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Venous occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Vessel perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1862" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="1941" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="1827" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="1761" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="165" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="184" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="168" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="166" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="118" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="116" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="137" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="310" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="366" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="352" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="367" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="194" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="240" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="212" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="262" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="140" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="168" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="162" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="173" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="308" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="332" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="327" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="291" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="172" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="185" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="132" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="125" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="969" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="939" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="938" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="779" subjects_at_risk="4140"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="254" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="224" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="215" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="206" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="129" subjects_at_risk="4131"/>
                <counts group_id="E2" subjects_affected="138" subjects_at_risk="4157"/>
                <counts group_id="E3" subjects_affected="124" subjects_at_risk="4140"/>
                <counts group_id="E4" subjects_affected="152" subjects_at_risk="4140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

